|Report ID : RNR-78459||Category : Biotechnology||Published Date : May 2017|
|Publisher : 9Dimen||Pages : 150||Format : PDF|
Global Platelet Rich Plasma Market: Trend Analysis and Forecast to 2022 The report segments the platelet rich plasma market by source and by application. The market segmentation based on source includes autologous, homologous, and allogenic. Global Platelet Rich Plasma Market: Trend Analysis and Forecast to 2022 Figure : Global Platelet Rich Plasma Market – Expansion Strategies Platelet rich plasma is plasma with more platelets than what is typically found in blood. To develop a plasma rich platelet preparation, blood must first be drawn from a patient. The platelets are separated from other blood cells and their concentration is increased during a process called centrifugation, after that the increased concentration of platelets is combined with remaining blood. Platelet rich plasma has a strong effect in the early phase of healing. Furthermore, platelet rich plasma is used for ligament and tendon injuries, knee osteoarthritis, degenerative knee cartilage and chronic elbow necessities, muscle strain and tears. In 2014, the Global Platelet Rich Plasma Market was valued at USD 140.0 million, while in 2015, the market size of global platelet rich plasma market surpassed USD 155 million. The global platelet rich plasma market is projected to grow with a CAGR between 12 % and 13% during 2016-2022 and reach USD XXX million by 2022. Increasing chronic disease population, increasing number patients suffering with orthopedic injuries, rising number of cosmetic surgeries, and increasing awareness about benefits associated with platelet rich plasma are key factors driving the growth of this market over forecast period. However, high cost associated with medical devices used for treatment and threats associated with PRP therapy are the key restraining factors affecting the growth of global platelet rich plasma market. Nevertheless, growing geriatric population and development of new applications of PRP technologies are likely to bring more opportunities to this market for major players and new entrants. Segments Covered: The report segments the platelet rich plasma market by source and by application. The market segmentation based on source includes autologous, homologous, and allogenic. Moreover, based on application the global platelet rich plasma market is segmented into orthopedic surgery, cosmetic surgery, general surgery, neurosurgery and other surgeries (urology, cardiothoracic, oral and maxillofacial and periodontal). Cosmetic surgery is the fastest growing segment in global platelet rich plasma market due to increasing awareness among people about better appearance and for enhancing personality. Geographic Coverage and Analysis: The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). North America is accounted as the largest growing region and majority share in 2015 supported by increasing number of orthopedic and cosmetic surgeries. Furthermore, presence of leading market players in the region and increasing awareness among the people about PRP therapy will continue the dominance of North America over the forecast period. However, Asia Pacific is expected to witness a healthy growth in the market due to rise in PRP therapy in the region. Further, increasing number of medical devices as well as highly developing healthcare infrastructure in the region is expected to accelerate growth in this market by 2022. Moreover, rising demand of cosmetic surgeries, increasing awareness among sports players about platelet rich plasma therapies in the emerging markets of Asia are anticipated to grow PRP market in the region at the highest CAGR over the forecast period. Companies Profiled: Harvest Technologies Corporation Arthrex, Inc. Estar Technologies Ltd. Zimmer Biomet DePuy Synthes, Inc Stryker Corporation AdiStem Ltd. Cesca Therapeutics, Inc. Eclipse Aesthetics Emcyte Corporation Nuo Therapeutics Regen Lab SA Exactech Inc. Report Highlights: The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of platelet rich plasma globally as well as regionally. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of platelet rich plasma market. Moreover, the study highlights current market trends and provides forecast from 2016 to 2022. We also have highlighted future trends in the platelet rich plasma market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. The report also provides in depth analysis of regulatory framework pertaining to Platelet Rich Plasma Market. This will help the companies to understand the regulatory compliances, supports, barriers in the Platelet Rich Plasma market.This section highlights key amendments and their implication on Platelet Rich Plasma market in the short run as well as in the long run.This report will help manufacturers, suppliers and distributors of the platelet rich plasma market to understand the present and future trends in this market and formulate their strategies accordingly.
1. Report Overview 1.1 Report Description 1.2 Research Methods 1.3 Research Approaches 2. Executive Summary 3. Platelet Rich Plasma Market Overview 3.1 Introduction 3.2 Market Dynamics 3.3 Drivers 3.4 Restraints 3.5 Opportunities 3.6 Challenges 3.7 Porter’s Five Forces Analysis 3.8 IGR – Growth Matrix Analysis 3.9 Competitive Landscape in the Platelet Rich Plasma Market 3.10 : Regulatory Framework analysis by region 3.10.1: North America 3.10.2 Europe 3.10.3 RoW (Including APAC, and LATAM) 4. Global Platelet Rich Plasma Market, by Source Type, (USD Million) 2014 – 2022 4.1 Introduction 4.2 Autologous 4.3 Homologous 4.4 Allogenic 5. Global Platelet Rich Plasma Market, by Application, (USD Million) 2014 – 2022 5.1 Introduction 5.2 Orthopedic Surgery 5.3 Cosmetic Surgery 5.4 General Surgery 5.5 Neurosurgery 5.6 Others 6. Global Platelet Rich Plasma Market, by Region, (USD Million) 2014 – 2022 6.1 Introduction 6.2 North America 6.2.1 North America Platelet Rich Plasma Market, by Source Type (USD Million) 6.2.2 North America Platelet Rich Plasma Market, by Application (USD Million) 6.3 Europe 6.3.1 Europe Platelet Rich Plasma Market, by Source Type (USD Million) 6.3.2 Europe Platelet Rich Plasma Market, by Application (USD Million) 6.4 Asia Pacific 6.4.1 Asia Pacific Platelet Rich Plasma Market, by Source Type (USD Million) 6.4.2 Asia Pacific Platelet Rich Plasma Market, by Application (USD Million) 6.5 Latin America 6.5.1 Latin America Platelet Rich Plasma Market, by Source Type (USD Million) 6.5.2 Latin America Platelet Rich Plasma Market, by Application (USD Million) 6.6 Rest of the World 6.6.1 RoW Platelet Rich Plasma Market, by Source Type (USD Million) 6.6.2 RoW Platelet Rich Plasma Market, by Application (USD Million) 7. Companies Profiled 7.1 Harvest Technologies Corporation 7.2 Arthrex, Inc. 7.3 Zimmer Biomet 7.4 DePuy Synthes, Inc 7.5 Stryker Corporation 7.6 AdiStem Ltd. 7.7 Cesca Therapeutics, Inc. 7.8 Emcyte Corporation 7.9 Estar Technologies Ltd. 7.10 Eclipse Aesthetics, LLC. 7.11 Nuo Therapeutics 7.12 Regen Lab SA 7.13 Exactech Inc. 7.14 Others